MED Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Mediplantex National Pharmaceutical JSC

Watchlist Manager

Watchlist

Price: 27 800 VND -9.74% Market Closed

Market Cap: ₫228.3B

M	Mediplantex National Pharmaceutical JSC VN:MED	VN
S	Siemens AG DUS:SIE	DE
B	Brunello Cucinelli SpA F:8BU	IT
A	Amphenol Corp F:XPH	US
	TE Connectivity Ltd NYSE:TEL	CH
B	Bank of China Ltd XMUN:W8V	CN
K	Kajima Corp XMUN:KAJ	JP
	Value and Indexed Property Income Trust PLC LSE:VIP	UK
	i3 Interactive Inc OTC:BLITF	CA
F	Franco-Nevada Corp F:3FO	CA

Profitability Summary

Mediplantex National Pharmaceutical JSC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

22%

Sustainable 3Y Average Gross Margin

22%

Gross Margin is Increasing

20% > 22%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

5% > 7%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

3% > 5%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-4%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.